Showing results (1241-1250 of 3,153) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|March 15, 2013
Comparative study of IDH1 mutations in gliomas by immunohistochemistry and DNA sequencingShipra Agarwal, Mehar Chand Sharma, Prerana Jha, et al.
Neuro-Oncology|May 4, 2013
Bifocal intracranial tumors of nongerminomatous germ cell etiology: diagnostic and therapeutic implicationsAyal A Aizer, Roshan V Sethi, E Tessa Hedley-Whyte, et al.
Neuro-Oncology|April 2, 2013
Can the prognosis of individual patients with glioblastoma be predicted using an online calculator?Christopher Parks, James Heald, Gregory Hall, et al.
Neuro-Oncology|March 6, 2013
Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot studyDeanna H Pafundi, Nadia N Laack, Ryan S Youland, et al.
Neuro-Oncology|March 6, 2013
Involved field radiation therapy after surgical resection of solitary brain metastases--mature resultsEileen P Connolly, Maya Mathew, Moses Tam, et al.
Neuro-Oncology|March 14, 2013
Prognostic significance of the aggregative perivascular growth pattern of tumor cells in primary central nervous system diffuse large B-cell lymphomaMiaoxia He, Changjing Zuo, Jianjun Wang, et al.
Neuro-Oncology|December 25, 2012
Comparing routes of delivery for nanoliposomal irinotecan shows superior anti-tumor activity of local administration in treating intracranial glioblastoma xenograftsPin-Yuan Chen, Tomoko Ozawa, Daryl C Drummond, et al.
Neuro-Oncology|February 22, 2012
Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degenerationIñigo Rojas-Marcos, Geraldine Picard, David Chinchón, et al.
Neuro-Oncology|September 24, 2014
Contemporary murine models in preclinical astrocytoma drug developmentRobert S McNeill, Mark Vitucci, Jing Wu, et al.
Neuro-Oncology|October 11, 2014
Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer NetworkDamien C Weber, Yucai Wang, Robert Miller, et al.
Pageof 316